Interatrial block in hypertrophic cardiomyopathy: Associations with left atrial remodeling and adverse atrial outcomes
Heart Rhythm · 2026-08 · 23 (8) · e1354-e1362
DOI: 10.1016/j.hrthm.2026.01.040 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Heart Rhythm, 2026-08. Verfasst von Leydimar Adel Anmad-Shihadeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitari Joan XXIII, Tarragona, Spain; Pere Virgili Health Research Institute (IISPV), Tarragona, Spain. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Atrial Remodeling, Interatrial Block, Heart Atria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Carlos III Health Institute, Ministerio de Ciencia e Innovación, Department of Health.
Abstract (Originalsprache)
BACKGROUND: Interatrial block (IAB) has been associated with atrial fibrillation (AF) and stroke in broader cardiovascular populations. Whether these associations extend to hypertrophic cardiomyopathy (HCM) and how IAB relates to underlying left atrial (LA) remodeling remain unknown. OBJECTIVE: This study aimed to investigate the prevalence, morphofunctional correlates, and prognostic value of IAB in patients with HCM. METHODS: This multicenter study included 259 patients with HCM without a history of AF/stroke. IAB was defined by a P-wave duration of >120 ms. Associations between morphologic and functional parameters of the LA and IAB were assessed using cardiac magnetic resonance imaging. The primary composite endpoint was new-onset AF, transient ischemic attack, or ischemic stroke. RESULTS: IAB was present in 10% of the cohort. Patients with IAB exhibited larger LA diameter (median 47.4 vs 43.2 mm; P = .022), larger indexed maximum LA volume (median 52.5 vs 46.9 mL/m2; P = .043), impaired LA ejection fraction (median 48% vs 51%; P = .043), reduced LA reservoir strain (median 22.0% vs 29.3%; P = .018), and reduced LA conduit strain (median 8.3% vs 12.1%; P = .012). During a median 5.8-year follow-up, IAB was independently associated with a 2-fold increased risk of the composite endpoint (hazard ratio 2.11; 95% confidence interval 1.13-3.95; P = .019) and new-onset AF (hazard ratio 2.10; 95% confidence interval 1.07-4.16; P = .031). CONCLUSION: In patients with HCM, IAB is associated with significant LA structural and functional impairments, indicative of advanced atrial cardiomyopathy. Its presence was independently associated with an increased risk of incident AF and stroke, suggesting its value as a simple, accessible electrocardiographic marker for enhanced risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hospital Universitari Joan XXIII, Tarragona, Spain; Pere Virgili Health Research Institute (IISPV), Tarragona, Spain.
- Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
- Department of Cardiology, Hospital Universitari Joan XXIII, Tarragona, Spain.
- Department of Cardiology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARD-H…
- Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre + (MUMC +), Maastricht, The Netherlands.
- Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Centre de Medicina Comparativa i Bioimatge (CMCiB), Badalona, Barcelona, Spain.
Förderung
- Carlos III Health Institute
- Ministerio de Ciencia e Innovación
- Department of Health
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
- European Commission
- Generalitat de Catalunya
Zitieren
APA
Anmad-Shihadeh, L. A., Teis, A., Sabate, M., Casas, G., De Raffele, M., Weerts, J., Limeres, J., Guillen Marzo, M., Rodríguez Palomares, J. F., Delgado, V., & Cediel, G. (2026). Interatrial block in hypertrophic cardiomyopathy: Associations with left atrial remodeling and adverse atrial outcomes. Heart Rhythm, 23(8), e1354-e1362. https://doi.org/10.1016/j.hrthm.2026.01.040
Vancouver
Anmad-Shihadeh LA, Teis A, Sabate M, Casas G, De Raffele M, Weerts J, et al. Interatrial block in hypertrophic cardiomyopathy: Associations with left atrial remodeling and adverse atrial outcomes. Heart Rhythm. 2026;23(8):e1354-e1362. doi:10.1016/j.hrthm.2026.01.040
BibTeX
@article{AnmadShihadeh2026,
author = {Anmad-Shihadeh, Leydimar Adel and Teis, Albert and Sabate, Marta and Casas, Guillem and De Raffele, Martina and Weerts, Jeremy and Limeres, Javier and Guillen Marzo, Marta and Rodríguez Palomares, Jose F and Delgado, Victoria and Cediel, German},
title = {Interatrial block in hypertrophic cardiomyopathy: Associations with left atrial remodeling and adverse atrial outcomes},
journal = {Heart Rhythm},
year = {2026},
volume = {23},
number = {8},
pages = {e1354--e1362},
doi = {10.1016/j.hrthm.2026.01.040}
}
EUVIMED